Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong-Reference-Cited by-同舟云学术

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

Author:

Cheung Tak Hong¹,Cheng Sally Shuk Yee²,Hsu Danny²,Wing-Lei Wong Queenie²,Pavelyev Andrew³,Sukarom Isaya⁴,Saxena Kunal³

Affiliation:

1. Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China

2. Global Medical and Scientific Affairs, MSD Hong Kong, Hong Kong, China

3. Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA

4. Center for Observational and Real-world Evidence, MSD Thailand, Bangkok, Thailand

Funder

Merck Sharp & Dohme LLC

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

Reference71 articles.

2. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP);Markowitz LE;MMWR Recomm Rep,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献